BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7270347)

  • 1. [Effects of ticlopidine on blood circulation and thrombin-induced platelet aggregation in experimental diabetic rats- and it's efficacy for remedy of diabetic retinopathy (author's transl)].
    Fujie K; Fujie Y
    Nippon Ganka Gakkai Zasshi; 1981 Mar; 85(3):242-9. PubMed ID: 7270347
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis.
    Kohga S; Kinjo M; Tanaka K; Ogawa H; Ishihara M; Tanaka N
    Cancer Res; 1981 Nov; 41(11 Pt 1):4710-4. PubMed ID: 7306988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part I: Cardiovascular effects.
    Akashi A; Tamura K; Hirohashi M; Watanabe K; Kasahara A
    Arzneimittelforschung; 1980; 30(3):409-14. PubMed ID: 7387750
    [No Abstract]   [Full Text] [Related]  

  • 5. [Migraine or transient ischemic attacks in a patient with essential thrombocythaemia. Treatment with ticlopidine (author's transl)].
    Bousser MG; Conard J; Lecrubier C; Bousser J
    Ann Med Interne (Paris); 1980; 131(2):87-90. PubMed ID: 7396326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of platelet aggregation inhibition].
    Abiko Y; Ashida S
    Rinsho Byori; 1979; Suppl 40():169-80. PubMed ID: 233105
    [No Abstract]   [Full Text] [Related]  

  • 8. Ticlopidine - an antiplatelet drug: effects in human volunteers.
    O'Brien JR; Etherington MD; Shuttleworth RD
    Thromb Res; 1978 Aug; 13(2):245-54. PubMed ID: 694843
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)].
    Renner C; Guilmet D; Curtet JM
    Nouv Presse Med; 1980 Nov; 9(43):3249-51. PubMed ID: 7454568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
    Ashida S; Sakuma K; Abiko Y
    Thromb Res; 1980 Mar; 17(5):663-71. PubMed ID: 7385100
    [No Abstract]   [Full Text] [Related]  

  • 11. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats.
    De La Cruz P; Arrebola M; González-Correa A; Martinez-Cerdán E; Moreno A; de la Cuesta FS
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):204-10. PubMed ID: 12595963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interactions of ticlopidine and aspirin in normal subjects.
    Thebault JJ; Blatrix CE; Blanchard JF; Panak EA
    J Int Med Res; 1977; 5(6):405-11. PubMed ID: 590598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
    Lee H; Paton RC; Ruan C; Caen JP
    Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ticlopidine as something more than a platelet antiaggregant].
    Villaverde C; Cánovas M; Padró T; Navarro C
    Arch Farmacol Toxicol; 1984 Aug; 10(2):121-32. PubMed ID: 6517621
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of long term administration of ticlopidine on platelet function and hemostatic variables.
    Conard J; Lecrubier C; Scarabin PY; Horellou MH; Samama M; Bousser MG
    Thromb Res; 1980 Oct; 20(1):143-8. PubMed ID: 7209871
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenetic mechanisms of platelet hyperaggregation in diabetics (author's transl)].
    Amado Señars JA; García-Conde Bru J; Merino Sánchez J; Benet Monforte I
    Sangre (Barc); 1981; 26(4):409-16. PubMed ID: 7027491
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental model of venous thrombosis in rats and effect of some agents.
    Kumada T; Ishihara M; Ogawa H; Abiko Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):189-203. PubMed ID: 7404498
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention by ticlopidine of platelet consumption during extracorporeal circulation for heart surgery and lack of effect on operative and postoperative bleeding.
    Installe E; Gonzalez M; Schoevaerdts JC; Tremouroux J
    J Cardiovasc Pharmacol; 1981; 3(6):1174-83. PubMed ID: 6173516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hematological toxicity of ticlopidine? (author's transl)].
    de Gramont A; Canuel C; Krulik M; Bauters F; Degos L; Marty M; Najean Y
    Nouv Rev Fr Hematol (1978); 1982; 24(1):35-7. PubMed ID: 7071010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.